Person

Andrew M. Dahl

SVP, Corporate Controller, Edwards Lifesciences

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$98K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 31, 2026EWSale544$91.06$50K
May 29, 2026EWSale568$86.08$49K

SEC reporting-owner ID (CIK) 2022347 · all filings on EDGAR